The Fatty Liver Index: a Simple and Accurate Predictor of Hepatic Steatosis in the General Population

Overview

Journal BMC Gastroenterol

Publisher Biomed Central

Specialty Gastroenterology

Date 2006 Nov 4

PMID 17081293

Citations 1111

Authors

Giorgio Bedogni

Stefano Bellentani

Lucia Miglioli

Flora Masutti

Marilena Passalacqua

Anna Castiglione

Claudio Tiribelli

Affiliations

Soon will be listed here.

Abstract

Background: Fatty liver (FL) is the most frequent liver disease in Western countries. We used data from the Dionysos Nutrition & Liver Study to develop a simple algorithm for the prediction of FL in the general population.

Methods: 216 subjects with and 280 without suspected liver disease were studied. FL was diagnosed by ultrasonography and alcohol intake was assessed using a 7-day diary. Bootstrapped stepwise logistic regression was used to identify potential predictors of FL among 13 variables of interest [gender, age, ethanol intake, alanine transaminase, aspartate transaminase, gamma-glutamyl-transferase (GGT), body mass index (BMI), waist circumference, sum of 4 skinfolds, glucose, insulin, triglycerides, and cholesterol]. Potential predictors were entered into stepwise logistic regression models with the aim of obtaining the most simple and accurate algorithm for the prediction of FL.

Results: An algorithm based on BMI, waist circumference, triglycerides and GGT had an accuracy of 0.84 (95%CI 0.81-0.87) in detecting FL. We used this algorithm to develop the "fatty liver index" (FLI), which varies between 0 and 100. A FLI < 30 (negative likelihood ratio = 0.2) rules out and a FLI > or = 60 (positive likelihood ratio = 4.3) rules in fatty liver.

Conclusion: FLI is simple to obtain and may help physicians select subjects for liver ultrasonography and intensified lifestyle counseling, and researchers to select patients for epidemiologic studies. Validation of FLI in external populations is needed before it can be employed for these purposes.

Citing Articles

GDF15 Circulating Levels Are Associated with Metabolic-Associated Liver Injury and Atherosclerotic Cardiovascular Disease.

Girona J, Guardiola M, Barroso E, Garcia-Altares M, Ibarretxe D, Plana N Int J Mol Sci. 2025; 26(5).

PMID: 40076667 PMC: 11900571. DOI: 10.3390/ijms26052039.

Fatty Liver Index vs. Biochemical-Anthropometric Indices: Diagnosing Metabolic Dysfunction-Associated Steatotic Liver Disease with Non-Invasive Tools.

Demirci S, Sezer S Diagnostics (Basel). 2025; 15(5).

PMID: 40075812 PMC: 11898660. DOI: 10.3390/diagnostics15050565.

Pentraxin-3 as a poor marker of fibrosis in metabolic dysfunction-associated steatotic liver disease among older adults: findings from the PolSenior2 substudy.

Owczarek A, Musialik J, Stefanski A, Mossakowska M, Zieba K, Wiecek A Front Med (Lausanne). 2025; 12:1445973.

PMID: 40066165 PMC: 11891235. DOI: 10.3389/fmed.2025.1445973.

Adherence to the planetary health diet index and metabolic dysfunction-associated steatotic liver disease: a cross-sectional study.

Qiu X, Shen S, Jiang N, Lu D, Feng Y, Yang G Front Nutr. 2025; 12:1534604.

PMID: 40051965 PMC: 11882404. DOI: 10.3389/fnut.2025.1534604.

Sex differences in predicting dyslipidemia using polygenic risk score with fatty liver index and fibrotic nonalcoholic steatohepatitis index.

Kim S, Yoo H Sci Rep. 2025; 15(1):7849.

PMID: 40050666 PMC: 11885555. DOI: 10.1038/s41598-025-92766-3.

References

Whitmer R, Gunderson E, Barrett-Connor E, Quesenberry Jr C, Yaffe K . Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study. BMJ. 2005; 330(7504):1360. PMC: 558283. DOI: 10.1136/bmj.38446.466238.E0. View

Reaven G . The metabolic syndrome: is this diagnosis necessary?. Am J Clin Nutr. 2006; 83(6):1237-47. DOI: 10.1093/ajcn/83.6.1237. View

Marchesini G, Natale S, Manini R, Agostini F . Review article: the treatment of fatty liver disease associated with the metabolic syndrome. Aliment Pharmacol Ther. 2005; 22 Suppl 2:37-9. DOI: 10.1111/j.1365-2036.2005.02593.x. View

Bellentani S, Saccoccio G, Masutti F, Croce L, Brandi G, Sasso F . Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med. 2000; 132(2):112-7. DOI: 10.7326/0003-4819-132-2-200001180-00004. View

Kushner R, Blatner D . Risk assessment of the overweight and obese patient. J Am Diet Assoc. 2005; 105(5 Suppl 1):S53-62. DOI: 10.1016/j.jada.2005.02.014. View

Fiori G, Facchini F, Pettener D, Rimondi A, Battistini N, Bedogni G . Relationships between blood pressure, anthropometric characteristics and blood lipids in high- and low-altitude populations from Central Asia. Ann Hum Biol. 2000; 27(1):19-28. DOI: 10.1080/030144600282343. View

Bellentani S, Tiribelli C, Saccoccio G, Sodde M, Fratti N, De Martin C . Prevalence of chronic liver disease in the general population of northern Italy: the Dionysos Study. Hepatology. 1994; 20(6):1442-9. DOI: 10.1002/hep.1840200611. View

Bellentani S, Bedogni G, Miglioli L, Tiribelli C . The epidemiology of fatty liver. Eur J Gastroenterol Hepatol. 2004; 16(11):1087-93. DOI: 10.1097/00042737-200411000-00002. View

Bedogni G, Miglioli L, Masutti F, Tiribelli C, Marchesini G, Bellentani S . Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology. 2005; 42(1):44-52. DOI: 10.1002/hep.20734. View

10.

Bedogni G, Pietrobelli A, Heymsfield S, Borghi A, Manzieri A, MORINI P . Is body mass index a measure of adiposity in elderly women?. Obes Res. 2001; 9(1):17-20. DOI: 10.1038/oby.2001.3. View

11.

Angulo P . Nonalcoholic fatty liver disease. N Engl J Med. 2002; 346(16):1221-31. DOI: 10.1056/NEJMra011775. View

12.

Bugianesi E, McCullough A, Marchesini G . Insulin resistance: a metabolic pathway to chronic liver disease. Hepatology. 2005; 42(5):987-1000. DOI: 10.1002/hep.20920. View

13.

Twisk J, Kemper H, van Mechelen W, Post G, Van Lenthe F . Body fatness: longitudinal relationship of body mass index and the sum of skinfolds with other risk factors for coronary heart disease. Int J Obes Relat Metab Disord. 1998; 22(9):915-22. DOI: 10.1038/sj.ijo.0800695. View

14.

Poynard T, Ratziu V, Naveau S, Thabut D, Charlotte F, Messous D . The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosis. Comp Hepatol. 2005; 4:10. PMC: 1327680. DOI: 10.1186/1476-5926-4-10. View

15.

Bellentani S, Tiribelli C . The spectrum of liver disease in the general population: lesson from the Dionysos study. J Hepatol. 2001; 35(4):531-7. DOI: 10.1016/s0168-8278(01)00151-9. View

16.

Fan J, Zhu J, Li X, Chen L, Li L, Dai F . Prevalence of and risk factors for fatty liver in a general population of Shanghai, China. J Hepatol. 2005; 43(3):508-14. DOI: 10.1016/j.jhep.2005.02.042. View

17.

Durnin J, Womersley J . Total body fat, calculated from body density, and its relationship to skinfold thickness in 571 people aged 12-72 years. Proc Nutr Soc. 1973; 32(1):45A. View

18.

Steyerberg E, Harrell Jr F, Borsboom G, Eijkemans M, Vergouwe Y, Habbema J . Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. J Clin Epidemiol. 2001; 54(8):774-81. DOI: 10.1016/s0895-4356(01)00341-9. View

19.

Bedogni G, Bellentani S . Fatty liver: how frequent is it and why?. Ann Hepatol. 2004; 3(2):63-5. View

20.

Farin H, Abbasi F, Reaven G . Body mass index and waist circumference correlate to the same degree with insulin-mediated glucose uptake. Metabolism. 2005; 54(10):1323-8. DOI: 10.1016/j.metabol.2005.04.021. View